WASHINGTON (Reuters) - U.S. President Donald Trump on Wednesday touted the use of convalescent plasma as a treatment for COVID-19 and suggested a reported decision by regulators to put on hold an emergency authorization for its use could be politically motivated.
"I've heard fantastic things about convalescent plasma," Trump told a briefing.
